Exponent CEO Catherine Corrigan Buys Shares in Company

Catherine Corrigan, the Chief Executive Officer of Exponent, Inc. (NasdaqGS: EXPO), made a significant purchase of company stock on June 25, 2026. She acquired 7,872 shares at an average price of $25.41, totaling approximately $200,027. This insider transaction was not part of a pre-arranged trading plan.

Insider Buying and Selling at Exponent, Inc.

Catherine Corrigan, Exponent's CEO, was active in buying and selling the company's shares recently. On June 25, 2026, she purchased 7,872 shares at $25.41 each. Earlier in June, she sold 4,119 shares at $57.13 under a planned transaction. Additionally, on June 15, she bought 5,605 shares at an average price of $26.96.

Other Institutional Activity in Exponent, Inc.

Several major institutional investors adjusted their holdings in Exponent, Inc. BlackRock, Inc. reduced its stake by 95,655 shares, ending with about 6,068,812 shares valued at $396 million. Kayne Anderson Rudnick Investment Management cut 256,799 shares, holding 3,886,308 shares worth $254 million. On the other hand, Vanguard Portfolio Management LLC and Vanguard Capital Management LLC both opened new positions, acquiring 2,946,756 and 2,210,650 shares, respectively. State Street Corp increased its holdings by 33,910 shares, totaling 1,889,536 shares valued at $123 million.

Exponent, Inc. Stock Down 16.5%

Shares of Exponent, Inc. (NasdaqGS: EXPO) traded near $60.83 on Tuesday. The company has a market capitalization of approximately $2.95 billion and a P/E ratio of 28.4. Exponent's stock has a 52-week low of $51.91 and a high of $81.95, with a 50-day moving average of $60.43 and a 200-day moving average of $67.80. The company's current ratio is 2.40, with a quick ratio of 2.22 and a debt-to-equity ratio of 23.95.

Analysts Set New Price Targets

JP Morgan maintained its 'buy' rating for Exponent, Inc. with an updated price target of $80 on May 15, 2026. UBS also maintained a 'hold' rating with a target of $75 on May 1, 2026. Overall, the stock has a consensus rating leaning towards 'buy' with an average target price of $81.67, based on three analyst opinions.

About Exponent, Inc.

Exponent, Inc. is a consulting company providing scientific and engineering services across various industries. Headquartered in Menlo Park, California, the company operates through two segments: Engineering and Other Scientific, and Environmental and Health. Exponent serves a diverse clientele, including sectors like consumer products, energy, and technology. Dr. Catherine Ford Corrigan leads the company as its CEO, overseeing a workforce of over 1,000 employees.

Bottom Line

Catherine Corrigan's recent purchase of Exponent shares underscores her confidence in the company's future. While insider transactions can be insightful, they are just one piece of the puzzle for investors. Exponent's stock performance, institutional activity, and analyst ratings provide a comprehensive view of the company's market position. As always, it's important to remember that 13F filings and insider trades reflect past actions and may not indicate current intentions.